$75 DISCOUNTIF YOU REGISTER

ON OR BEFORE JAN 10, 2019

CE.MAYO.EDU/HEMONC2019

OMNI SCOTTSDALE RESORT & SPA AT MONTELUCIASCOTTSDALE, ARIZONAFEBRUARY 15–17, 2019

Mayo Clinic School of Continuous Professional Development

Alan H. Bryce, M.D. Rafael Fonseca, M.D.

COURSE HIGHLIGHTS• Comprehensive update and management strategies for key hematologic and

oncologic diseases

• New data and best practices for practicing physicians and the entire healthcare team

• Half-day symposium on CAR-T therapy

• Case and panel discussions

• Renowned guest and Mayo Clinic faculty

• Continuing education credit offered for physicians, pharmacists and nurses

LEARNING OBJECTIVESUpon conclusion of this program, participants should be able to:

• Describe the appropriate patient population for CAR-T therapy.

• Select appropriate patients for neoadjuvant therapy for breast cancer.

• Relate diagnostic criteria for smoldering and active myeloma, including revised International Myeloma Working Group guidelines.

• List donor sources available for allogeneic stem cell transplantation.

• Review the latest developments in cellular therapy applied to cancer.

• State the role of immune checkpoint blockade in the treatment of bladder cancer.

• Identify two strategies for incorporating Cancer Survivorship Care Plans into clinical practice.

• Recall state-of-the-art data applicable to management of early stage HER2+ breast cancer (neoadjuvant and adjuvant).

• Recognize the role of pathology and nuclear medicine imaging in making treatment decisions for patients with neuroendocrine tumors.

TARGET AUDIENCEThis course is designed for physicians practicing in hematology and oncology, as well as physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in the diagnosis and treatment of patients with hematologic and oncologic disorders.

REGISTRATION

COURSE DIRECTORS

Registration Fee On/Before Jan 10, 2019 After Jan 10, 2019

Physicians/Scientists $600 USD $675 USD

Fellows, Residents, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists

$400 USD

$475 USD

Please visit ce.mayo.edu/cancellation for more information.

CE.MAYO.EDU/HEMONC2019

LODGING & ACCOMMODATIONS Omni Scottsdale Resort & Spa at Montelucia 4949 East Lincoln Drive | Scottsdale, Arizona 85253 | Telephone: (888) 627-3010 Reservations: www.omnihotels.com/hotels/scottsdale-montelucia/meetings/HEMONC2019

A special group rate of $299 (USD), per room per night, plus applicable city/state sales tax, single or double occupancy, is available for course participants and guests.

A reduced resort fee of $10, per room, per night, includes basic guestroom wireless internet, local and toll free calls, access to the fitness center, Kasbah and Oasis Pools, in-room coffee and tea, and USA Today newspaper, upon request. Self-parking is complimentary. Group rates apply three days prior to and three days post-course dates, based upon availability.

To ensure accommodations, make your reservation before the room block fills or by January 14, 2019, via website or telephone, and reference “Mayo Clinic Hematology & Oncology.”

Attendees are responsible for their own reservations. The standard hotel reservation cancellation policy will apply to individual reservations unless otherwise specified.

Mayo School of CPD is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.

TRAVEL Hertz is offering a reduced daily rate for participants attending the course. Visit Hertz, www.hertz.com, and enter CV03NR0014 in the respective “discount or promo code” section. Special rates include unlimited mileage and are subject to availability. Advance reservations are recommended as cars are subject to availability; blackout dates may apply.

SuperShuttle vans offer airport transportation to and from area hotels and businesses. To make reservations, visit www.supershuttle.com or call (800) 258-3826 or (602) 244-9000.

RECREATIONAL ACTIVITIES Visit www.experiencescottsdale.com or www.visitphoenix.com for leisure activities.

CE.MAYO.EDU/HEMONC2019PROGRAM AT-A-GLANCEA complete program schedule is on the website:

FRIDAY, FEBRUARY 15, 2019

MYELOMAManagement of Newly Diagnosed Multiple Myeloma Including Stem Cell TransplantationBenefits of Maintenance Therapy and the Treatment of the First Relapse: A Second ChanceSubsequent Relapse

MYELOID DISORDERSMDS / MPN Overlap SyndromesAllogeneic BMT: Who to Refer and Donor SelectionUpdate on Myelodysplastic Syndromes

NON-HODGKINS LYMPHOMAPrimary Central Nervous System Lymphoma: Update 2019Update on Diffuse Large B Cell Lymphoma TherapyMantle Cell Lymphoma Update

BENIGN HEMATOLOGY / CHRONIC LYMPHOCYTIC LEUKEMIAThromboembolism Management and ThrombocytopeniaDirect Oral Anticoagulants: Guidelines for Clinical PracticeHow Do I Assess My CLL Patients’ Risk for Progression and What is My Best Choice for Upfront Therapy in 2019?

SATURDAY, FEBRUARY 16, 2019

CAR-T CELL THERAPYFrom Model T to Tesla: A Brief History of CARs for LymphomaUpdates on CAR-T Cell Therapy in LymphomaCARs and More: How Fast Are They Moving?Myeloma CAR-T TherapyThe Future of CAR-T Cells Panel Discussion

SOLID TUMORSUpdate on Diagnosis and Treatment of GliomaNeoadjuvant and Adjuvant Therapy for Lung CancerUpdate in the Management of Metastatic Lung CancerIntegrating New Therapeutics into Bladder Cancer TreatmentSequencing Therapies in Metastatic Kidney CancerCardio-Oncology: A Multidisciplinary Approach to Managing Cardiovascular Complications in Cancer PatientsIncorporating Cancer Survivorship Care Plans into a Busy Clinical Practice: Meeting Clinical Guidelines and Addressing Patient Need

SUNDAY, FEBRUARY 17, 2019

SOLID TUMORSNovel Approaches to HER2+ and Triple Negative Breast CancersAdjuvant Management of Hormone Receptor Positive Breast CancerFamilial Cancer Syndromes: An Under-Diagnosed ProblemHepatobiliary CancerAdvances in the Diagnosis and Management of Neuroendocrine TumorsClinical Updates in the Treatment of Advanced Colorectal and Gastro-Esophageal Cancers

CREDIT In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA: Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE: Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 18.0 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity. Participants must complete the entire activity and are required to complete an online evaluation(s) to earn credit.

Visit the activity’s website for additional information regarding the ACPE credit offering.

AAFP: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

ANCC: Participants can earn up to 20.0 ANCC nursing contact hours commensurate with the extent of their participation in the activity. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

FACULTYCourse Directors

Alan H. Bryce, M.D. Rafael Fonseca, M.D.

Guest Faculty

Jeremy S. Abramson, M.D. Assistant Professor of Medicine

Harvard Medical School Clinical Director, Lymphoma Program Dana-Farber / Harvard Cancer Center

Massachusetts General Hospital Boston, Massachusetts

Patrick Forde, M.B.B.Ch. Assistant Professor of Oncology

Johns Hopkins University School of Medicine Baltimore, Maryland

Guillermo Garcia-Manero, M.D. Professor

Deputy Chair, Translational Research Chief, Section of Myelodysplastic Syndromes

Department of Leukemia, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center

Houston, Texas

Jonathan E. Rosenberg, M.D. Chief, Genitourinary Medical Oncology

Division of Solid Tumor Oncology Memorial Sloan Kettering Cancer Center

New York, New York

Mayo Clinic Faculty

Sikander Ailawadhi, M.D.

Noel M. Arring, D.N.P., R.N., O.C.N.

Tanios S. Bekaii-Saab, M.D.

Mitesh J. Borad, M.D.

Alan H. Bryce, M.D.

Januario Castro, M.D.

Rafael Fonseca, M.D.

Thorvardur R. Halfdanarson, M.D.

Thai H. Ho, M.D., Ph.D.

Neil E. Kay, M.D.

Yi Lin, M.D., Ph.D.

Farouk Mookadam, M.B., B.Ch.

Donald W. Northfelt, M.D.

Brian Patrick O’Neill, M.D.

Leslie J. Padrnos, M.D.

Harshita R. Paripati, M.D.

Mrinal Patnaik, M.B.B.S.

Edith A. Perez, M.D.

Alyx Porter, M.D.

Allison C. Rosenthal, D.O.

Niloy Jewel Samadder, M.D.

Lisa Z. Sproat, M.D.

Keith Stewart, M.B., Ch.B.

Prakash Vishnu, M.B.B.S.

Thomas E. Witzig, M.D.

MA

YO

CL

INIC

1340

0 E

ast S

hea

Bou

leva

rdS

cott

sdal

e, A

rizon

a 85

259

Em

ail:

mca

.cm

e@m

ayo.

edu

Ph

on

e: (4

80) 3

01-4

580

©20

18 M

ayo

Foun

dat

ion

for

Med

ical

Ed

ucat

ion

and

Res

earc

h |

MC

8300

-54

May

o C

linic

Sch

ool o

f Con

tinuo

us P

rofe

ssio

nal D

evel

opm

ent u

ses

mul

tiple

mai

ling

lists

and

can

not a

lway

s el

imin

ate

dup

licat

ions

. If y

ou h

ave

rece

ived

mul

tiple

bro

chur

es, p

leas

e p

ost o

r sh

are

them

with

inte

rest

ed c

olle

ague

s.

$75

DISC

OUNT

FOR

EAR

LY R

EGIS

TRAT

ION

(offe

r ex

pire

s Ja

nuar

y 10

, 201

9)

CE.M

AYO.

EDU/

HEM

ONC2

019

OMNI

SCO

TTSD

ALE

RESO

RT &

SPA

AT

MON

TELU

CIA

SCOT

TSDA

LE, A

RIZO

NAFE

BRUA

RY 1

5–17

, 201

9